Malek Chamoun
10% owner at Sunshine Biopharma, Inc (SBFM) since October 2022
Malek Chamoun has filed 1 insider report with the SEC since October 2022, as 10% owner at Sunshine Biopharma, Inc (SBFM). The latest filing, on October 26, 2022, is a Form 3: Malek Chamoun became an insider at Sunshine Biopharma, Inc (SBFM).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Malek Chamoun is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| 10% ownersince October 2022 | 3,700,000 | $2.23 | Oct 26, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Other insiders at the same companies
Questions about Malek Chamoun
- What is Malek Chamoun's role at Sunshine Biopharma, Inc?
- Malek Chamoun reports to the SEC as 10% owner at Sunshine Biopharma, Inc (SBFM), according to the latest filing on October 26, 2022.
- How many shares does Malek Chamoun own?
- After the latest filing that states it, Malek Chamoun directly owned 3,700,000 shares of Sunshine Biopharma, Inc (SBFM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Malek Chamoun bought or sold stock recently?
- No open-market purchases or sales by Malek Chamoun are on file.
- How do I get alerts when Malek Chamoun files?
- Follow Malek Chamoun on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Malek Chamoun (SEC CIK 0001951769). Totals count each trade once, skipping amendments whose original is on file, from Oct 26, 2022 on. View on SEC EDGAR · Get this as JSON